Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation.
Tolosa-Ridao C, Cascos E, Rodríguez-Lobato LG, Pedraza A, Suárez-Lledó M, Charry P, Solano MT, Martinez-Sanchez J, Cid J, Lozano M, Rosiñol L, Esteve J, Urbano-Ispizua Á, Fernández-Avilés F, Martínez C, Carreras E, Díaz-Ricart M, Rovira M, Salas MQ. Tolosa-Ridao C, et al. Among authors: rovira m. Bone Marrow Transplant. 2024 Mar 23. doi: 10.1038/s41409-024-02270-x. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38521885
At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program.
Ruiz-Boy S, Pedraza A, Prat M, Salas MQ, Carcelero E, Riu-Viladoms G, Suárez-Lledó M, Monge-Escartín I, Rodríguez-Lobato LG, Martínez-Roca A, Rovira M, Martínez C, Gallego C, Urbano-Ispizua Á, Sánchez J, Marcos MÁ, Fernández-Avilés F. Ruiz-Boy S, et al. Among authors: rovira m. Pharmaceuticals (Basel). 2023 Dec 18;16(12):1741. doi: 10.3390/ph16121741. Pharmaceuticals (Basel). 2023. PMID: 38139867 Free PMC article.
Improving the EASIX' predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation.
Escribano-Serrat S, Rodríguez-Lobato LG, Suárez-Lledó M, Pedraza A, Charry P, Cid J, Lozano M, Esteve J, Rosiñol L, Fernández-Avilés F, Carreras E, Díaz-Ricart M, Martínez C, Rovira M, Salas MQ. Escribano-Serrat S, et al. Among authors: rovira m. Bone Marrow Transplant. 2024 Mar 23. doi: 10.1038/s41409-024-02267-6. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38521886 No abstract available.
Increased Serum Levels of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) in Mobilized Healthy Donors with G-CSF: A Cohort Study.
Cid J, Guinetti-Ortiz K, Charry P, Carbassé G, de Pablo-Miró M, Rubia L, Garcia M, Alcaraz-Quiles J, Cascos E, Martínez-Cibrian N, Salas MQ, Suárez-Lledó M, Rosiñol L, Fernández-Avilés F, Martínez C, Rovira M, Lozano M. Cid J, et al. Among authors: rovira m. Transfus Med Rev. 2024 Apr;38(2):150824. doi: 10.1016/j.tmrv.2024.150824. Epub 2024 Mar 15. Transfus Med Rev. 2024. PMID: 38569349
Cyclophosphamide-free mobilisation increases safety while preserving the efficacy of autologous haematopoietic stem cell transplantation in refractory Crohn's disease patients.
Giordano A, Rovira M, Veny M, Barastegui R, Marín P, Martínez C, Fernández-Avilés F, Suárez-Lledó M, Domènech A, Serrahima A, Lozano M, Cid J, Ordás I, Fernández-Clotet A, Caballol B, Gallego M, Vara A, Masamunt MC, Giner À, Teubel I, Esteller M, Corraliza AM, Panés J, Salas A, Ricart E. Giordano A, et al. Among authors: rovira m. J Crohns Colitis. 2024 May 17:jjae076. doi: 10.1093/ecco-jcc/jjae076. Online ahead of print. J Crohns Colitis. 2024. PMID: 38757210
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia.
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, Ribera JM, Antelo G, Martin AA, Lopez Godino O, Torrent A, Villalba M, Chorao P, Sanz MA, Sanz J; Grupo Español de Trasplante Hematopoyético (GETH). Mora E, et al. Among authors: rovira m. Bone Marrow Transplant. 2024 May 16. doi: 10.1038/s41409-024-02298-z. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38755458
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.
Snowden JA, Badoglio M, Labopin M, Giebel S, McGrath E, Marjanovic Z, Burman J, Moore J, Rovira M, Wulffraat NM, Kazmi M, Greco R, Snarski E, Kozak T, Kirgizov K, Alexander T, Bader P, Saccardi R, Farge D; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP); EBMT Paediatric Working Party (PWP); Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT); EBMT (JACIE). Snowden JA, et al. Among authors: rovira m. Blood Adv. 2017 Dec 20;1(27):2742-2755. doi: 10.1182/bloodadvances.2017010041. eCollection 2017 Dec 26. Blood Adv. 2017. PMID: 29296926 Free PMC article.
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee.
Greco R, Alexander T, Del Papa N, Müller F, Saccardi R, Sanchez-Guijo F, Schett G, Sharrack B, Snowden JA, Tarte K, Onida F, Sánchez-Ortega I, Burman J, Castilla Llorente C, Cervera R, Ciceri F, Doria A, Henes J, Lindsay J, Mackensen A, Muraro PA, Ricart E, Rovira M, Zuckerman T, Yakoub-Agha I, Farge D. Greco R, et al. Among authors: rovira m. EClinicalMedicine. 2024 Feb 10;69:102476. doi: 10.1016/j.eclinm.2024.102476. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361991 Free PMC article. Review.
Younger unrelated donors may be preferable over HLA match in the PTCy era: A study from the ALWP of the EBMT.
Sanz J, Labopin M, Choi G, Kulagin A, Peccatori J, Vydra J, Remenyi PP, Versluis J, Rovira M, Blaise D, Labussiere-Wallet H, Montoro J, Sica S, Meijer E, Itälä-Remes M, Schaap N, Bulabois CE, Piemontese S, Mohty M, Ciceri F. Sanz J, et al. Among authors: rovira m. Blood. 2024 Mar 29:blood.2023023697. doi: 10.1182/blood.2023023697. Online ahead of print. Blood. 2024. PMID: 38657278
Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation.
Marco DN, Molina M, Guio AM, Julian J, Fortuna V, Fabregat-Zaragoza VL, Salas MQ, Monge-Escartín I, Riu-Viladoms G, Carcelero E, Roma JR, Llobet N, Arcarons J, Suárez-Lledó M, Rosiñol L, Fernández-Avilés F, Rovira M, Brunet M, Martínez C. Marco DN, et al. Among authors: rovira m. Pharmaceuticals (Basel). 2024 Apr 25;17(5):553. doi: 10.3390/ph17050553. Pharmaceuticals (Basel). 2024. PMID: 38794124 Free PMC article.
549 results